Logo image
Back
New advances in radiation oncology for gynecologic cancer
Journal article   Peer reviewed

New advances in radiation oncology for gynecologic cancer

Luther W. Brady, Marvin Rotman and Felipe A. Calvo
Cancer, v 71(S4), pp 1652-1659
15 Feb 1993
DOI: https://doi.org/10.1002/cncr.2820710432
PMID: 8431901
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

brachytherapy continuous infusion chemotherapy hyperthermia intraarterial chemotherapy intraoperative radiation therapy radiation therapy
In 1992, the American Cancer Society anticipates that there will be 1,130,000 new cases of invasive cancer diagnosed in the United States. About 66,500 will be invasive cancers of the cervix, uterus, and ovary. About 22,400 patients will die during 1992, with 50–60% of those deaths being due to persistent local regional disease. Data are available to suggest that a reduction in local failure will be reflected by an increase in survival free of disease. In 1992, major efforts are being made to reduce the incidence of local failure. Three areas in this regard are innovative uses of brachytherapy, intraarterial chemotherapy and radiation therapy, and continuous infusion chemotherapy and radiation therapy. These new techniques show significant reduction in local failure with associated improvement in survival. The data will be presented to illustrate the impact of these techniques.

Metrics

11 Record Views
8 citations in Web of Science
11 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Oncology
Logo image